New study by the St Gallen consortium estimates the cost of one approved drug at $6.16 Billion. 7 of the top 16 pharma companies demonstrated negative R&D productivity.
OpenEvidence, which is valued at $425 million, is taking on one of AI’s big engineering challenges: large language models whose training is stuck in the past.
Amazon is continuing its expansion into the health space with the launch of a new generative AI tool called HealthScribe, meant to take over some time-consuming administrative tasks of doctor’s offices and clinics, the company said.
With a new $59 million investment, digital health startup K Health is looking to scale its AI technology in hospitals, starting with new strategic investor Cedars-Sinai.
In 2023, several breakthroughs have shaken the academic community. Freezing entire organs to sub-zero temperatures for future transplantation is now a reality.
Sanofi made a very important official announcement that went largely unnoticed by the media but has enormous implications for the company and pharmaceutical industry
At Cortical Labs, CEO Hon Weng Chong is building biological computers that he hopes will not just surpass AI, but supercharge growth of other companies.
Neuralink is one of many brain implant companies hoping to restore lost functions like sight and movement and Musk hopes it will one day help humans merge with artificial intelligence.